Company news
Imagion Biosystems Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Completion of Renounceable Rights Issue
November 21, 2019
Pro-Rata Renounceable Rights Issue - Amended Timetable
October 28, 2019
Investor Presentation
September 8, 2019
Appendix 4D and Half Year Report
August 29, 2019
Imagion Biosystems receives A$2 million in R&D tax incentive
July 24, 2019
FDA Breakthrough Device Designation
July 18, 2019
Imagion Biosystems successfully completes toxicology study
May 22, 2019
Imagion Biosystems receives R&D Advanced Overseas Finding
May 13, 2019
IBX receives order related to cancer treatment
April 10, 2019
IBX receives US patent related to treatment of disease
March 11, 2019
FY2018 Appendix 4E and Preliminary Report
February 28, 2019
Imagion Biosystems Raises $4.3M Via Rights Issue
November 18, 2018
Despatch of Rights Issue Offer Documents
October 3, 2018
Rights Issue Offer Document
September 23, 2018
Market Announcement - Reinstatement to official quotation
September 20, 2018
Pro-Rata Non-Renounceable Rights Issue
September 19, 2018
Voluntary Suspension
September 16, 2018
Imagion Biosystems Hits Nanoparticle Formulation Milestone
September 9, 2018
Response to Appendix 4C Query
August 16, 2018
MD Anderson Cancer Center Takes Equity Stake in IBX
May 23, 2018
IBX Announces Relocation of U.S. Operations to San Diego
April 2, 2018
FY2017 Appendix 4E and Financial Report
February 28, 2018
Quarterly Update and Appendix 4C
January 30, 2018
Imagion Biosystems Secures Nanoparticle Manufacturer
October 9, 2017
Appendix 4D and Half-Year Report
August 31, 2017
Imagion Biosystems Initiates MagSense Instrument Development
August 15, 2017
Appendix 4C & Restated Statements for year ended 31 Dec 2016
July 31, 2017
Imagion Biosystems identifies key operational objectives
July 12, 2017
Admission to Official List
June 21, 2017
Decks
The 5 newest of 28 decks. Every deck is listed under its year.
- Investor Presentation (September 2026)
Investor deck · 12 slides · Sep 4, 2026
- Investor Presentation (May 2026)
Investor deck · 21 slides · May 26, 2026
- Emerging Growth Conference (October 2025)
Conference · 18 slides · October 2025
- Investor Presentation (July 2025)
Investor deck · 12 slides · Aug 4, 2025
- Investor Presentation (July 2025)
Investor deck · 12 slides · July 2025